Table II Quantification of apolipoproteins and cholesterols in maternal plasma and nonpregnant controls
Apolipoprotein A-II (mg/dL)Apolipoprotein A-I (mg/dL)
Menstrual4–12 weeks16–22 weeks24–28 weeks35–38 weeksMenstrual4–12 weeks35–38 weeks
Averages25.323.730.032.934.193.1104.1241.2
S.E.2.52.51.81.84.18.514.827.7
p valueap = 0.009p = 0.009
Apolipoprotein C-III (mg/dL)Apolipoprotein C-II (mg/dL)
Menstrual4–12 weeks16–22 weeks24–28 weeks35–38 weeksMenstrual4–12 weeks35–38 weeks
Averages10.59.616.624.341.58.18.712.7
S.E.1.11.92.62.86.80.60.51.1
p valueap < 0.0001p = 0.007
VLDL/LDL cholesterol (mg/dL)HDL (mg/dL)
Menstrual4–12 weeks16–22 weeks24–28 weeks35–38 weeksMenstrual4–12 weeks16–22 weeks24–28 weeks35–38 weeks
Averages139.9142.0223.0250.1274.242.135.748.252.846.0
S.E.18.415.815.127.823.65.88.26.35.05.5
p valueap = 0.0003p = 0.0084
  • a p values calculated by paired t-test (2 groups) or repeated measures ANOVA (4 groups) for pregnant cohorts.